Advisory Services Network’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Advisory Services Network’s Portfolio BCLI Stock Details BCLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-787	Closed	-$45K	–	1559
2021 Q2	$45K	Buy	787 +120	+18%	+$6.41K	﹤0.01%	2063
2021 Q1	$38K	Buy	+667	New	+$50.4K	﹤0.01%	1266
2020 Q4	–	Sell	-47	Closed	-$12K	–	3307
2020 Q3	$12K	Buy	+47	New	+$9.63K	﹤0.01%	2315
2020 Q2	–	Sell	-33	Closed	-$2K	–	1196
2020 Q1	$2K	Hold	33	–	–	﹤0.01%	2716
2019 Q4	$2K	Hold	33	–	–	﹤0.01%	2825
2019 Q3	$2K	Hold	33	–	–	﹤0.01%	2615
2019 Q2	$2K	Hold	33	–	–	﹤0.01%	2613
2019 Q1	$2K	Hold	33	–	–	﹤0.01%	2309
2018 Q4	$2K	Hold	33	–	–	﹤0.01%	2282
2018 Q3	$2K	Hold	33	–	–	﹤0.01%	2288
2018 Q2	$2K	Hold	33	–	–	﹤0.01%	2250
2018 Q1	$2K	Hold	33	–	–	﹤0.01%	2361
2017 Q4	$2K	Hold	33	–	–	﹤0.01%	2338
2017 Q3	$2K	Buy	+33	New	+$2.14K	﹤0.01%	2124
2017 Q2	–	Sell	-44	Closed	-$3K	–	2290
2017 Q1	$3K	Buy	+44	New	+$2.29K	﹤0.01%	1862

Other funds holding BCLI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AHB

Abner Herrman & Brock Jersey City, New Jersey $1.05B AUM 42.66% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Advisory Services Network's BCLI Position: Q3 2021 in Review

Advisory Services Network sold out of BRAINSTORM CELL THERAPUTC (BCLI) in Q3 2021, closing a stake of 787 shares — an estimated $45K sold.

Advisory Services Network first reported a position in BCLI in Q1 2017 and held it in 15 quarters. The position peaked at $45K in Q2 2021. 52 funds tracked by Wall St. Rank hold BCLI as of Q3 2021.

Advisory Services Network reported no remaining BRAINSTORM CELL THERAPUTC position as of Q3 2021 after selling out during the quarter.
Advisory Services Network sold 787 BRAINSTORM CELL THERAPUTC shares in Q3 2021, an estimated $45K.
Advisory Services Network first reported a position in BRAINSTORM CELL THERAPUTC in Q1 2017 and held it in 15 quarters.
Advisory Services Network's BRAINSTORM CELL THERAPUTC position peaked at $45K in Q2 2021.
52 funds tracked by Wall St. Rank held BRAINSTORM CELL THERAPUTC as of Q3 2021.

Based on Advisory Services Network's 13F filing for Q3 2021, filed 5 Nov 2021.